NASDAQ · Healthcare
Evidence
57/100
Thin evidence
TECHi stance
Balanced watch
Model confidence 47/100 · 67/76 inputs
Chart
Trade access
Affiliate disclosure: TECHi may earn a commission on links to broker partners. Read more.
Prices update fastest. Fundamentals, analyst data, and news update on their own schedules, so check these timestamps before comparing signals.
Price time means the latest available trade or regular-market close. Other times show when that section was checked or published.
Investor playbook
The current snapshot gives bulls more to work with, but the watch list still controls timing.
Use it for
Entry timing, risk check, and catalyst scan
What has to keep working for US investors to stay interested.
Cash yield
4.8%$10.18B free-cash-flow base.
Estimate revisions
+32 net32 EPS estimate increases vs 0 cuts in 30 days.
Where the dashboard says the thesis can break or get crowded.
Balance-sheet drag
-17.8%-$37.87B net balance-sheet position.
The playbook is derived from quote, analyst, financial, news, and trend snapshots. It is a research workflow aid, not a buy or sell recommendation.
Upcoming events
AMGN reports on Nov 2, 2026 during the AMC session.
Countdown
55 days out
The stock has traded between $269.77 and $447.03 over the past 52 weeks, carries a market capitalization of $213.2B, trades at 24.51x trailing earnings, and yields 2.3% in dividends. Sell-side analysts rate AMGN Buy across 43 ratings and carry an average price target of $389.69. AMGN's record close stands at $447.03, set on Aug 25, 2026.
Buy analyst tone.
| Enterprise value | $251.07B |
| Price / sales | 5.60 |
| Price / book | 18.24 |
| Operating margin | 29.99% |
| Return on assets | 9.14% |
| EPS (TTM) | $16.09 |
| Beta (5Y) | 0.43 |
Benchmark context
Compare against its sector ETF and the broad market.
Help · FAQ
2 answers covering leadership, and sector context.
TECHi displays provider-supplied values only when the corresponding field is present.